相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings
Simone Baiardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
Aline Dorey et al.
JAMA NEUROLOGY (2015)
Cerebrospinal fluid P-tau181P: biomarker for improved differential dementia diagnosis
Hanne Struyfs et al.
FRONTIERS IN NEUROLOGY (2015)
The future of blood-based biomarkers for Alzheimer's disease
Kim Henriksen et al.
ALZHEIMERS & DEMENTIA (2014)
Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases
Matthias Schmitz et al.
NEUROBIOLOGY OF AGING (2014)
Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease Results From the Swedish Mortality Registry
Tobias Skillback et al.
JAMA NEUROLOGY (2014)
Diagnostic value of cerebrospinal fluid markers
Piero Parchi et al.
NATURE REVIEWS NEUROLOGY (2013)
PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2
Franc Llorens et al.
PRION (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA
Piero Parchi et al.
ACTA NEUROPATHOLOGICA (2012)
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
Katharina Stoeck et al.
BRAIN (2012)
Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease
Mauricio Torres et al.
PLOS ONE (2012)
Human Prion Diseases in The Netherlands (1998-2009): Clinical, Genetic and Molecular Aspects
Casper Jansen et al.
PLOS ONE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
Gianluigi Zanusso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease
Brit Mollenhauer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
ATYPICAL CASE OF ALZHEIMER'S DISEASE MIMICKING CREUTZFELDT-JAKOB DISEASE: INTEREST OF CEREBROSPINAL FLUID BIOMARKERS IN THE DIFFERENTIAL DIAGNOSIS
Rachid Mahmoudi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
CSF biomarkers predict a more malignant outcome in Alzheimer disease
A. K. Wallin et al.
NEUROLOGY (2010)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
Codistribution of Amyloid β Plaques and Spongiform Degeneration in Familial Creutzfeldt-Jakob Disease With the E200K-129M Haplotype
Nupur Ghoshal et al.
ARCHIVES OF NEUROLOGY (2009)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Inter-Laboratory Assessment of PrPSc Typing in Creutzfeldt-Jakob Disease: A Western Blot Study within the NeuroPrion Consortium
Piero Parchi et al.
BRAIN PATHOLOGY (2009)
Total Prion Protein Levels in the Cerebrospinal Fluid are Reduced in Patients with Various Neurological Disorders
Felix Meyne et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M. I. Kester et al.
NEUROLOGY (2009)
Rapidly progressive Alzheimers disease and elevated 14-3-3 proteins in cerebrospinal fluid
Skanda Jayaratnam et al.
AGE AND AGEING (2008)
Fast cognitive decline at the time of dementia diagnosis:: A major prognostic factor for survival in the community
Laure Carcaillon et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease
RJ Castellani et al.
NEUROLOGY (2004)
Rapidly progressive Alzheimer's disease mimicking Creutzfeldt-Jakob disease
S Reinwald et al.
JOURNAL OF NEUROLOGY (2004)
14-3-3 protein in the CSF of patients with rapidly progressive dementia
N Huang et al.
NEUROLOGY (2003)
β-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
J Wiltfang et al.
ANNALS OF NEUROLOGY (2003)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2000)
分享论文
